Investor Relations
Partnerships are integral to Harbour BioMed's strategy to build a fully integrated biopharmaceutical company.
-
Mar 28, 2024
2023 Annual Results Online Conference
-
Dec 15, 2023
HBM 9033 Out-license to Pfizer
-
Aug 29, 2023
2023 Interim Results Online Conference
-
Mar 29, 2023
2022 Annual Results Online Conference
-
Dec 12, 2022
2022 Investor Day
Copyright © 2022 Harbour BioMed. All Rights Reserved 沪ICP备19015946号-1